- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03729440
Evaluation of Esophageal Injuries in Corrosives in Assiut Governorate - Experimental Comparison Between Different Treatments
November 1, 2018 updated by: MKMAbdelrahim, Assiut University
Esophageal stricture is one of the most common sequelae of caustic injury.
Up to 70% of patients with grade IIB and more than 90% of patients with grade III injury are likely to develop esophageal stricture.
Stricture formation can be prevented by suppressing fibrosis and scar formation therefore; many agents are explored for treatment on various models in this subject.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
In spite of the multiple efforts to educate the public, Caustic ingestion maintains its place as an important public health issue due to the availability of caustic agents and the loose regulatory control on its production.
All the cases will be evaluated by detailed history and thorough physical examination and necessary investigations.
Patient's sheet will include; name, age, sex, occupation, residence, type of administrated substance, route and mode of exposure, symptoms and sighs (pain , vomiting , diarrhea) and any received treatment.
Study Type
Observational
Enrollment (Anticipated)
50
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 months to 50 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Cases diagnosed as acute corrosive toxicity which admitted to emergency unit Assiut University Hospital ,children university hospital and ministry of health hospitals in Assiut in duration of one year.
Description
Inclusion Criteria:
-1- All the cases with the primary diagnosis of acute caustic injury will be included in the study.
2- Willing and able to comply with the study procedures and provide written informed consent to participate in the study.
Exclusion Criteria:
- 1- Caustic substance ingested patient with any chronic disease. 2- Patients with history of congenital esophageal stricture. 3- Unable to provide informed consent. 4- Unlikely to return at 8 weeks. 5- Ingestion of substances other than corrosive (co-ingestion).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
corrosive patients
|
assessment of development of complications
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
fate of cases
Time Frame: 6 months
|
development of esophageal stricture or not
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
January 1, 2019
Primary Completion (Anticipated)
December 1, 2019
Study Completion (Anticipated)
December 1, 2020
Study Registration Dates
First Submitted
November 1, 2018
First Submitted That Met QC Criteria
November 1, 2018
First Posted (Actual)
November 2, 2018
Study Record Updates
Last Update Posted (Actual)
November 2, 2018
Last Update Submitted That Met QC Criteria
November 1, 2018
Last Verified
November 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- EsophagealCorrosiveAssiut
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Clinico-epidemiological Characteristics of Corrosive Patients Presenting at Assiut Governorate
-
Assiut UniversityUnknownEpidemiologic Data of Some Synthetic Cannibinoids Toxicity in Patients Presenting at Assiut University Hospital, Psychiatric Hospital of Ministry of Health) | Proportion of Acute and Chronic Abusers of Synthetic Cannibinoids Among Cases of Illicit Drugs Abuser in Studied SitesEgypt
Clinical Trials on development of complications or not
-
University Hospital, AngersRecruiting
-
Peking Union Medical College HospitalNot yet recruitingSurgery | IVF | Myoma;Uterus
-
Shengyun LinCompleted
-
University of LjubljanaUniversity Medical Centre LjubljanaCompletedDiabetes Mellitus, Type 1 | Periodontitis | Periodontal Diseases | Pregnancy Complications | Delivery Complication | Pregnancy in Diabetic
-
Wang HongxiaTianjin Eye HospitalCompletedRefractive Error - Myopia AxialChina
-
Colaris, Joost, M.D.UnknownChild | Treatment | Fracture | Forearm | DistalNetherlands
-
Hospices Civils de LyonCompletedPediatric | Head Trauma Injury | Pediatric Head Trauma | Isolated Skull FractureFrance
-
Leap of Faith TechnologiesNational Cancer Institute (NCI)CompletedLymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Leukemia | Psychosocial Effects of Cancer and Its TreatmentUnited States
-
Maxima Medical CenterCompletedChronic or Recurrent Appendicitis